Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study.

Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study.

OBJECTIVE: To examine the degree to which use of β blockers, statins, and diuretics in patients with impaired glucose tolerance and other cardiovascular risk factors is associated with new onset diabetes. DESIGN: Reanalysis of data from the Nateglinide and Valsartan in Impaired Glucose Tolerance Out...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Shen, L, Shah, B, Reyes, E, Thomas, L, Wojdyla, D, Diem, P, Leiter, L, Charbonnel, B, Mareev, V, Horton, E, Haffner, S, Soska, V, Holman, R, Bethel, M, Schaper, F, Sun, J, McMurray, J, Califf, R, Krum, H
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	2013

Ижил төстэй зүйлс

Do Diuretics, Beta-Blockers, and Statins Increase the Risk of Diabetes in Patients with Impaired Glucose Tolerance? Insights from the NAVIGATOR Study
-н: Shen, L, зэрэг
Хэвлэсэн: (2012)

Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study
-н: Mcmurray, J, зэрэг
Хэвлэсэн: (2012)

Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension on clinical end points: a cohort study.
-н: McMurray, J, зэрэг
Хэвлэсэн: (2012)

Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
-н: Krum, H, зэрэг
Хэвлэсэн: (2010)

Association of non-alcoholic steatothepatitis with components of the metabolic syndrome in 43,509 patients screened for NAVIGATOR
-н: Bethel, A, зэрэг
Хэвлэсэн: (2005)

Prediabetes and the risk of diabetes.
-н: McMurray, J, зэрэг
Хэвлэсэн: (2012)

Determining the most appropriate components for a composite clinical trial outcome.
-н: Bethel, M, зэрэг
Хэвлэсэн: (2008)

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
-н: Califf, R, зэрэг
Хэвлэсэн: (2008)

Selection of antihypertensive therapy in elderly patients, combination therapy: thiazide-like diuretics and calcium channel blockers
-н: z. M. Galeyeva, зэрэг
Хэвлэсэн: (2018-12-01)

Rates of delirium associated with calcium channel blockers compared to diuretics, renin-angiotensin system agents, and beta-blockers: an electronic health records network study
-н: Harrison, P, зэрэг
Хэвлэсэн: (2020)

Antihypertension drugs in prevention of cognition disorder and dementia: focus on calcium channel blockers and diuretics
-н: O. D. Ostroumova, зэрэг
Хэвлэсэн: (2018-10-01)

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
-н: Currie, G, зэрэг
Хэвлэсэн: (2017)

Relations between Baseline Physical Activity by Pedometer Counts and Future Cardiovascular Events in the NAVIGATOR Study
-н: Kraus, W, зэрэг
Хэвлэсэн: (2012)

Integrated metabolomics analysis reveals mechanistic insights into variability in blood pressure response to thiazide diuretics and beta blockers
-н: Mai Mehanna, зэрэг
Хэвлэсэн: (2024-05-01)

Cardiologists should care about glucose: most people with CV disease or risk factors have diabetes or significant glycaemic abnormalities. Results of screening over 39,000 subjects for NAVIGATOR
-н: McMurray, J, зэрэг
Хэвлэсэн: (2004)

Quantifying the effects of diuretics and β-adrenoceptor blockers on glycaemic control in diabetes mellitus - a systematic review and meta-analysis
-н: Hirst, J, зэрэг
Хэвлэсэн: (2015)

A systematic review and meta-analysis of the effects of diuretics and beta-blockers on glycaemic control in diabetes mellitus
-н: Hirst, J, зэрэг
Хэвлэсэн: (2014)

Diuretics in patients with metabolic disturbances
-н: I. E. Chazova, зэрэг
Хэвлэсэн: (2007-04-01)

Diuretics in chronic heart failure management
-н: M. A. Gurevich, зэрэг
Хэвлэсэн: (2008-06-01)

Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
-н: McMurray, J, зэрэг
Хэвлэсэн: (2005)

Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: Results from NAVIGATOR
-н: Huffman, K, зэрэг
Хэвлэсэн: (2014)

Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial
-н: Preiss, D, зэрэг
Хэвлэсэн: (2012)

Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population.
-н: Bethel, M, зэрэг
Хэвлэсэн: (2009)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.
-н: Yates, T, зэрэг
Хэвлэсэн: (2014)

Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: results from NAVIGATOR.
-н: Huffman, K, зэрэг
Хэвлэсэн: (2014)

Association of Baseline Physical Activity by Pedometer Counts and Nutritional Behavior on Metabolic Syndrome in the NAVIGATOR Study
-н: Huffman, K, зэрэг
Хэвлэсэн: (2013)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis
-н: Yates, T, зэрэг
Хэвлэсэн: (2014)

Diuretics in chronic kidney disease
-н: A. I. Dyadyk, зэрэг
Хэвлэсэн: (2020-01-01)

Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database.
-н: de Vries, F, зэрэг
Хэвлэсэн: (2006)

Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database
-н: de Vries, F, зэрэг
Хэвлэсэн: (2006)

Risk factors for fatal and non-fatal cardiovascular events in 9306 subjects in the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial
-н: Mcmurray, J, зэрэг
Хэвлэсэн: (2011)

«Flexible combination» of diuretics with reduced sodium - an alternative to daily diuretic therapy in arterial hypertension management
-н: V. I. Kharchenko, зэрэг
Хэвлэсэн: (2006-10-01)

Diuretics in arterial hypertension: angels and demons
-н: S. V. Nedogoda
Хэвлэсэн: (2013-06-01)

ANTIHYPERTENSIVE EFFICACY AND VASOPROTECTIVE PROPERTIES OF A NEW COMBINATION OF BETA-BLOCKER, BISOPROLOL (2,5/5 MG) AND DIURETIC, HYDROCHLOROTHIAZIDE (6,25 MG)
-н: O. D. Ostroumova, зэрэг
Хэвлэсэн: (2016-01-01)

Rationale and design of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
-н: Bethel, M, зэрэг
Хэвлэсэн: (2009)

Chronic obstructive pulmonary disease and cardiovascular risk: insights from the NAVIGATOR trial.
-н: de Barros e Silva, P, зэрэг
Хэвлэсэн: (2014)

A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk
-н: Bethel, M, зэрэг
Хэвлэсэн: (2013)

A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk.
-н: Bethel, M, зэрэг
Хэвлэсэн: (2013)

Torasemide – loop diuretic with specific effects
-н: V. M. Gorbunov, зэрэг
Хэвлэсэн: (2006-10-01)

THIAZIDE DIURETICS IN TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION
-н: E. I. Chazov, зэрэг
Хэвлэсэн: (2022-12-01)